Intrapatient dose escalation at monthly interval if no GVHD:Dose level 1: 106/kg,Dose level 2: 107/kg,Dose level 3: 106/kg + IL-2,Dose level 4: 107/kg + IL-2;Starting 28 days after HSCT. The gene discussed is IL2; the disease is graft versus host disease.